West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 292,800 | 138,800 | 493,700 | 361,600 | 221,600 |
| Depreciation Amortization | 91,400 | 45,200 | 171,400 | 124,400 | 81,400 |
| Income taxes - deferred | N/A | N/A | -13,700 | N/A | N/A |
| Accounts receivable | N/A | N/A | 6,900 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 17,900 | N/A | N/A |
| Other Working Capital | -188,900 | -102,900 | 79,800 | -1,900 | -4,000 |
| Other Operating Activity | 18,600 | 8,800 | -1,200 | 19,600 | 7,500 |
| Operating Cash Flow | $213,900 | $89,900 | $754,800 | $503,700 | $306,500 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -85,900 | -42,700 | -285,900 | -209,800 | -146,500 |
| Investing Cash Flow | $-85,900 | $-42,700 | $-285,900 | $-209,800 | $-146,500 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 50,000 | N/A | N/A | 0 | 0 |
| Debt Repayment | -700 | -300 | -1,100 | -800 | -500 |
| Common Stock Issued | 16,300 | 7,500 | 18,200 | 13,600 | 9,600 |
| Common Stock Repurchased | -456,800 | -300,100 | -136,800 | -136,600 | -136,500 |
| Dividend Paid | -31,500 | -15,800 | -61,200 | -45,400 | -30,300 |
| Other Financing Activity | -50,800 | 0 | -4,200 | -4,200 | -4,200 |
| Financing Cash Flow | $-473,500 | $-308,700 | $-185,100 | $-173,400 | $-161,900 |
| Exchange Rate Effect | -10,000 | -8,400 | 22,900 | 23,400 | 27,000 |
| Beginning Cash Position | 791,300 | 791,300 | 484,600 | 484,600 | 484,600 |
| End Cash Position | 435,800 | 521,400 | 791,300 | 628,500 | 509,700 |
| Net Cash Flow | $-355,500 | $-269,900 | $306,700 | $143,900 | $25,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 213,900 | 89,900 | 754,800 | 503,700 | 306,500 |
| Capital Expenditure | -85,900 | -42,700 | -285,900 | -209,800 | -146,500 |
| Free Cash Flow | 128,000 | 47,200 | 468,900 | 293,900 | 160,000 |